| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/05/2000 | EP1015570A1 Fibrin microbeads and uses thereof |
| 07/05/2000 | EP1015483A1 Malaria polypeptides |
| 07/05/2000 | EP1015089A1 Blood processing systems and methods which optically derive the volume of platelets contained in a plasma constituent |
| 07/05/2000 | EP1015043A1 Methods for inhibiting rejection of transplanted tissues by bone grafting |
| 07/05/2000 | EP1015036A1 Improvements in or relating to expression of immunogenic substances |
| 07/05/2000 | EP1015025A1 T-cell vaccination for the treatment of multiple sclerosis |
| 07/05/2000 | EP1015024A1 Antigen presenting mesenchymal stem cells |
| 07/05/2000 | EP1015017A1 Implantable system with drug-eluting cells for on-demand local drug delivery |
| 07/05/2000 | EP1015005A1 Gene transfer with adenoviruses having modified fiber proteins |
| 07/05/2000 | EP1015004A1 Pharmaceutical and alimentary compositions containing bacteria of the genus acetobacter |
| 07/05/2000 | EP1015003A1 Transgenic autologous t-cell therapy in humans, and related compositions and kits |
| 07/05/2000 | EP1014926A1 Therapeutic and cosmetic compositions, their use and method for the preparation thereof |
| 07/05/2000 | EP1014880A1 Augmentation and repair of dermal, subcutaneous, and vocal cord tissue defects |
| 07/05/2000 | EP1014787A1 Adjuvant for transcutaneous immunization |
| 07/05/2000 | CN1258538A Health food made of silkworm for treating diabetes and hyperlipemia and its production process |
| 07/05/2000 | CN1258535A Kidney invigorating and blood circulation activating Chinese medicine preparation and its preparation process and application |
| 07/05/2000 | CN1258531A Wind evil-dispelling, meridian passage-dredging and pus-drawing out medicine powder |
| 07/05/2000 | CN1258527A Fast-acting piles-treating Chinese medicine preparation |
| 07/05/2000 | CN1258521A Medicine for treating cardiac and cerebral vascular diseases and its preparation |
| 07/05/2000 | CN1258514A Blood stasis removing analgesic plaster and its preparation |
| 07/05/2000 | CN1258511A Supercritical multiple bee glue extracting process |
| 07/05/2000 | CN1258510A Snail health products making process |
| 07/05/2000 | CN1258509A Beri-beri medicine powder |
| 07/05/2000 | CN1258508A Antibody gene chicken serum preparing method and cure instrument |
| 07/05/2000 | CN1054072C Hypotensor and its preparing method |
| 07/05/2000 | CN1054069C Process for preparing plaster for treating burn and scald for external use |
| 07/05/2000 | CN1054061C Powder for treating hypertension for external use |
| 07/05/2000 | CN1054056C Preparation of Chinese herb medicine for treating cervical vertebra syndrome |
| 07/05/2000 | CN1054051C Medicine for treating phthisis and its preparation |
| 07/05/2000 | CN1054049C External application plaster for hepatitis, hepatocirrhosis and hepatonecrosis |
| 07/05/2000 | CN1054047C Black-bone chicken, wolfberry fruit nutritive wine |
| 07/05/2000 | CN1054045C Health medicated wine |
| 07/04/2000 | US6084060 Amino acid sequence of protein that inhibits differentiation of progenitor cells; for expanding progenitor cell populations ex vivo to increase chances of engraftation and gene therapy |
| 07/04/2000 | US6083928 Applying topically to skin composition containing lipopolysaccharide extracted from klebsiella pneumoniae strain |
| 07/04/2000 | US6083925 Nucleic acid respiratory syncytial virus vaccines |
| 07/04/2000 | US6083720 Dodecahedral adenoviral protein complex, composition containing same and uses thereof |
| 07/04/2000 | US6083536 Super-critical lipid extract from mussels having anti-inflammatory activity |
| 07/04/2000 | US6083523 Implantable biocompatable immunoisolatory vehicle for delivery of selected therapeutic products |
| 07/04/2000 | US6083507 Composition for the elimination of hasmifl toxin buildup comprising quantities of gotu-kola, whole leaf aloe-vera, lactobacilli organism and folic acid |
| 07/04/2000 | US6083500 Novel strains of e. coli and methods for treating livestock with strains of the invention to inhibit growth of s. typhimurium as well as other pathogenic enterobacteria, such as e. coli 0157:h7, in the intestinal tract of treated |
| 07/04/2000 | US6082364 Pluripotential bone marrow cell line and methods of using the same |
| 07/04/2000 | CA2124792C Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
| 06/29/2000 | WO2000037659A1 Non-viral transfection vector |
| 06/29/2000 | WO2000037648A1 Protective antigen of group a streptococci (spa) |
| 06/29/2000 | WO2000037643A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 06/29/2000 | WO2000037635A2 Genetic suppressor elements against human immunodeficiency virus |
| 06/29/2000 | WO2000037612A1 SOMATIC CELLS WITH ABLATED Prp GENE AND METHODS OF USE |
| 06/29/2000 | WO2000037501A1 Removal/purification of serum albumins |
| 06/29/2000 | WO2000037487A1 αvβ6 INTEGRIN INHIBITORS |
| 06/29/2000 | WO2000037421A1 Nephronin: a series of compounds for treatment of infectious diseases and cancer |
| 06/29/2000 | WO2000037141A1 Combination chemotherapy |
| 06/29/2000 | WO2000037124A1 Injectable hyaluronic acid derivative with pharmaceuticals/cells |
| 06/29/2000 | WO2000037112A1 Pharmaceutical compositions comprising immortalised endothelial cells |
| 06/29/2000 | WO2000037111A1 Mammalian cell preparations optionally transfected with a gene coding for an active substance containing same |
| 06/29/2000 | WO2000037094A2 Therapeutic applications of flint polypeptides |
| 06/29/2000 | WO2000037091A1 Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof |
| 06/29/2000 | WO2000036919A1 Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues |
| 06/29/2000 | WO2000024437A8 Textured and porous silicone rubber |
| 06/29/2000 | WO2000012683A3 Stem cells bearing an fgf receptor on the cell surface |
| 06/29/2000 | WO2000006605A3 Heterominibodies |
| 06/29/2000 | CA2358508A1 Therapeutic applications of flint polypeptides |
| 06/29/2000 | CA2356987A1 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 06/29/2000 | CA2356244A1 Somatic cells with ablated prp gene and methods of use |
| 06/29/2000 | CA2355882A1 Mammalian cell preparations optionally transfected with a gene coding for an active substance containing same |
| 06/29/2000 | CA2355879A1 Pharmaceutical compositions comprising immortalised endothelial cells |
| 06/29/2000 | CA2355874A1 .alpha.v.beta.6 integrin inhibitors |
| 06/29/2000 | CA2355840A1 Nephronin: a series of compounds for treatment of infectious diseases and cancer |
| 06/29/2000 | CA2355836A1 Genetic suppressor elements against human immunodeficiency virus |
| 06/29/2000 | CA2355827A1 Removal/purification of serum albumins |
| 06/29/2000 | CA2355228A1 Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues |
| 06/29/2000 | CA2353790A1 Non-viral transfection vector |
| 06/29/2000 | CA2352326A1 Combination chemotherapy |
| 06/28/2000 | EP1013770A1 Non-viral transfection vector |
| 06/28/2000 | EP1013287A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 06/28/2000 | EP1013284A2 Purified forms of dnase |
| 06/28/2000 | EP1013278A1 The extract of pine needle and the use thereof |
| 06/28/2000 | EP1012321A2 Viral infection of cells using viral vectors |
| 06/28/2000 | EP1012320A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
| 06/28/2000 | EP1012295A1 Alphavirus rna replicon systems |
| 06/28/2000 | EP1012293A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 06/28/2000 | EP1012291A1 Multiple site delivery of adenoviral vector for the induction of angiogenesis |
| 06/28/2000 | EP1012283A1 Mage-3 peptides presented by hla class ii molecules |
| 06/28/2000 | EP1012259A2 Tumor targeted vector |
| 06/28/2000 | EP1012240A2 Cancer immunotherapy with semi-allogeneic cells |
| 06/28/2000 | EP1012239A1 Method and system for managing immunocompetent cell batches for delayed use |
| 06/28/2000 | EP1012238A1 Peptides and peptide-loaded antigen presenting cells for the activation of ctl |
| 06/28/2000 | EP1012232A1 Genetically modified tumor-targeted bacteria with reduced virulence |
| 06/28/2000 | EP1012163A1 A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium |
| 06/28/2000 | EP1011752A2 Cell processing systems |
| 06/28/2000 | EP1011734A1 Gene therapy vehicle comprising dermal sheath tissue |
| 06/28/2000 | EP1011732A1 Lineage-restricted neuronal precursors |
| 06/28/2000 | EP1011721A1 Vaginal lactobacillus medicant |
| 06/28/2000 | EP1011710A1 Methods and compositions for optimization of oxygen transport by cell-free systems |
| 06/28/2000 | EP1011699A1 Galactosidase modified submucosal tissue |
| 06/28/2000 | EP1011697A1 Targeted system for removing tumor cells from cell populations |
| 06/28/2000 | EP1011696A1 Treatment of stress and preconditioning against stress |
| 06/28/2000 | EP1011695A1 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 06/28/2000 | EP1011694A2 Conditioning for allogeneic stem cell transplantation |
| 06/28/2000 | EP1011656A2 A method for treating tension-type headache |
| 06/28/2000 | EP1011654A1 A method of modulating cellular activity |